Variables | Categories | Follow up status | CHR (95%CI) | P value | |
---|---|---|---|---|---|
Pregnant (%) | Censored (%) | ||||
Age | 15–24 | 20 (23.3%) | 66 (76.7%) | 2.12 (1.07, 4.19) | 0.032 |
25–34 | 78 (18.1%) | 172 (81.9%) | 1.65 (0.89, 3.05) | 0.109 | |
≥ 35 | 14 (11.3%) | 110 (88.7%) | (1) | ||
Residence | Urban | 55 (16.7%) | 1274 (83.3%) | (1) | |
Rural | 17 (18.7%) | 74 (81.3%) | 1.16 (0.67, 1.99) | 0.600 | |
Marital status | Never married | 9 (11.7%) | 68 (88.3%) | (1) | |
Married | 42 (21.9%) | 150 (78.1%) | 2.05 (1.00, 4.27) | 0.050 | |
Widowed | 11 (15.3%) | 61 (84.7%) | 1.45 (0.60, 3.50) | 0.407 | |
Divorced | 10 (12.7%) | 69 (87.3%) | 1.12 (0.45, 2.75) | 0.811 | |
Level of education | No formal education | 32 (17.3%) | 3153 (82.7%) | 0.72 (0.36, 1.48) | 0.376 |
Primary | 19 (16.8%) | 94 (83.2%) | 0.75 (0.35, 1.62) | 0.472 | |
Secondary | 11 (13.8%) | 69 (86.2%) | 0.54 (0.23, 1.27) | 0.159 | |
Certificate and above | 10 (23.8%) | 32 (76.2%) | (1) | ||
Number of Children’s | ≥ 2 children | 13 (9.1%) | 130 (90.9%) | (1) | |
< 2 children | 59 (21.3%) | 218 (78.7%) | 2.34 (1.28, 4.26) | 0.006 | |
Disease stage | Advanced | 20 (9.5%) | 190 (90.5%) | (1) | |
Unadvanced | 52 (24.8%) | 158 (75.2%) | 2.43 (1.45, 4.07) | 0.001 | |
BMI | < 18.5 kg/m2 | 17 (10.7%) | 142 (89.3%) | (1) | |
18.5-25 kg/m2 | 53 (22.7%) | 181 (77.3%) | 1.73 (1.00, 3.00) | 0.049 | |
> 25 kg/m2 | 2 (7.4%) | 25 (92.6%) | 0.50 (0.11, 2.16) | 0.351 | |
Functional status | Unable to working | 7 (6.6%) | 99 (93.4%) | (1) | |
Able to Working | 65 (20.7%) | 249 (79.3%) | 2.34 (1.07, 5.10) | 0.034 | |
Hemoglobin level | < 11 | 19 (9.5%) | 181 (90.5%) | (1) | |
≥ 11 | 53 (24.1%) | 167 (75.9%) | 2.26 (1.33, 3.81) | 0.002 | |
CD4 count level in cells/mm3 | < 200 | 19 (9.7%) | 176 (90.3%) | (1) | |
200–350 | 16 (17.2%) | 77 (82.8%) | 1.57 (0.81, 3.06) | 0.183 | |
> 350 | 37 (28.0%) | 95 (72.0%) | 2.62 (1.51, 4.56) | 0.002 | |
OIs | Yes | 29 (12.2%) | 209 (87.8%) | (1) | |
No | 43 (23.6%) | 139 (76.4%) | 1.81 (1.13, 2.89) | 0.014 | |
ARVs medication adherence | Not adhered | 4 (4.6%) | 83 (95.4%) | (1) | |
Adhered | 68 (20.4%) | 265 (79.6%) | 2.76 (1.00, 7.61) | 0.050 | |
Cotrimoxazole Prophylaxis | Yes | 32 (13.1%) | 212 (86.9%) | (1) | |
No | 40 (22.7%) | 136 (77.3%) | 1.60 (1.00, 2.54) | 0.049 | |
HIV serostatus disclosure | Not-disclosed | 21 (12.3%) | 149 (87.7%) | (1) | |
Disclosed | 51 (20.4%) | 199 (79.6%) | 1.69 (1.02, 2.82) | 0.036 |